NMC Health
Former United Arab Emirates healthcare and distribution group that entered administration after undisclosed debt and alleged financial irregularities were revealed.
Last updated October 22, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
NMC Health was a United Arab Emirates healthcare group and medical-distribution business founded by B. R. Shetty in Abu Dhabi in 1974 as the New Medical Centre. It developed from a single medical facility into one of the UAE's largest private healthcare providers, with hospitals, clinics, pharmacies, fertility and women's-health services, long-term care operations, rehabilitation facilities and related distribution activities. Its principal healthcare footprint was in the UAE, while acquisitions and operating arrangements extended the business into Saudi Arabia, the United Kingdom, Spain and other international markets. The group expanded in stages. It opened its first distribution division, NMC Trading, in 1981, initially supplying medicines to UAE pharmacies and later handling medical equipment, medical supplies, fast-moving consumer goods and educational products. From the mid-1990s, the healthcare business broadened beyond Abu Dhabi through facilities in Sharjah, Dubai, Al Ain and other emirates. Its hospital portfolio included general, specialty, women's and fertility-related operations. Several facilities received Joint Commission International accreditation in 2009, supporting the group's positioning as a professionally managed private healthcare provider. NMC Health became a publicly traded company on the London Stock Exchange in April 2012. Public-market access supported an acquisition-led strategy. The group bought or invested in businesses including Clínica Eugin in Spain, Dr. Sunny Healthcare Group, Provita, Americare Group and Fakih IVF. It also acquired or managed additional hospitals and healthcare assets in the UAE, expanded into Saudi Arabia through an investment in As Salama Hospital, and bought Aspen Healthcare in the United Kingdom in 2018. NMC Health also secured operating and management contracts, including an arrangement to manage Ruwais Hospital for ADNOC. The company's growth and public-market reputation were severely damaged in late 2019 and 2020. Short-seller Muddy Waters questioned NMC's accounts and alleged that the balance sheet understated debt. Subsequent investigations and internal reviews identified previously undisclosed financing facilities. The company reported that more than US$2.7 billion of facilities had not been disclosed to or approved by the board; estimates of total indebtedness rose substantially as further information emerged. The disclosures also raised concerns that some proceeds may have been used for purposes outside the group. Trading in NMC's London-listed shares was suspended, the Financial Conduct Authority opened an investigation, and senior executive Khalifa Butti Omeir Bin Yousef resigned in February 2020. NMC Health entered administration in the United Kingdom on 8 April 2020 after becoming insolvent. It subsequently sought Chapter 15 protection in the United States to assist administrators in dealing with US assets. The company's financial collapse also produced criminal complaints, creditor actions, employee-payment problems and restructuring proceedings. In December 2020, B. R. Shetty sold the company for a nominal one-dollar consideration to an Israeli-UAE consortium, according to the referenced account. In 2023, the UK Financial Conduct Authority censured NMC Health for market abuse connected with the understatement of debt by as much as US$4 billion. No financial penalty was imposed because the company was not expected to have funds remaining after creditor payments. NMC Health is therefore treated as a defunct corporate brand rather than an active operating healthcare group.
History
NMC Health began in Abu Dhabi in 1974, when B. R. Shetty founded the New Medical Centre. The business initially focused on medical services and gradually developed a recognizable private-healthcare presence in the UAE. In 1981, it established NMC Trading, a marketing and distribution division that supplied medicines to pharmacies. The distribution operation later expanded into medical equipment and supplies, fast-moving consumer goods and educational products, giving the group a second business line alongside healthcare services. From 1996 onward, NMC expanded geographically within the UAE. It opened an NMC clinic in Sharjah, followed by NMC Hospital in Deira, Dubai, in 1999. The NMC Specialty Hospital in Dubai opened in 2004, and another specialty hospital was established in Al Ain in 2008. The hospital operations received Joint Commission International accreditation in 2009. During this period, the group broadened its clinical scope across general care, specialist medicine, diagnostics, outpatient services, obstetrics, gynecology, fertility, pharmacy and related treatments. NMC Health entered the London Stock Exchange in April 2012. The listing marked a transition from a primarily UAE-based healthcare operator into an international public company. During 2012, it began managing Sheikh Khalifa General Hospital in Umm Al Quwain, acquired BR Medical Suites in Dubai Healthcare City and continued adding facilities in Abu Dhabi and Al Ain. In 2013, it added a day-surgery centre in Mohammed Bin Zayed City. Further facilities opened in 2014, including NMC Hospital in Dubai Investments Park, NMC Brightpoint Royal Women's Hospital and an NMC medical centre in Al Ain. The group pursued an acquisition-led international strategy from 2015. It acquired Spain-based Clínica Eugin, strengthening its fertility and women's-health offering from reproductive medicine through obstetrics and pediatrics. In the UAE, it acquired Dr. Sunny Healthcare Group, Provita and Americare Group, and purchased a 51 percent stake in Fakih IVF. Provita and Americare added long-term care, rehabilitation and related specialist capabilities. In 2016, NMC entered Saudi Arabia by acquiring a 70 percent stake in As Salama Hospital in Al Khobar and investing in a planned care centre in Jeddah. It also announced the acquisition of Al Zahra Hospital in the UAE. NMC continued to expand through management agreements and acquisitions. In 2017, Emirates Healthcare, owned by Abu Dhabi investment group KBBO, announced an operating and management arrangement with NMC Health for its healthcare assets. In March 2018, ADNOC selected NMC to manage Ruwais Hospital in the Al Dhafra region. In August 2018, NMC bought UK healthcare provider Aspen Healthcare for £10 million. By this period, the company described itself as an international healthcare network and distribution group, with operations extending across numerous countries and a large facility base. The growth story unraveled in late 2019. Muddy Waters questioned NMC's accounts and alleged that the balance sheet materially understated debt. The company began legal and internal reviews of shareholder interests and financing arrangements. In February 2020, executive vice chairman Khalifa Butti Omeir Bin Yousef resigned, shares were suspended, and the FCA opened an investigation. NMC subsequently disclosed more than US$2.7 billion in financing facilities that had not been reported to or approved by the board. The company stated that some proceeds might have been used for non-group purposes. Reported debt estimates rose from approximately US$2.1 billion to around US$5 billion as of June 2019 and were later estimated at approximately US$6.6 billion in March 2020. The crisis affected employees and creditors, with reports that many employees were not paid. On 8 April 2020, the UK High Court placed NMC Health into administration because of insolvency associated with alleged frauds. The company later filed for Chapter 15 bankruptcy protection in the United States. Abu Dhabi Commercial Bank filed a criminal complaint against NMC Health with the UAE Attorney General's Office in April 2020. In December 2020, Shetty sold the company for a nominal one-dollar consideration to an Israeli-UAE consortium. Debt trading and restructuring continued, including auctions of creditor positions by HSBC and Standard Chartered in 2021. In 2023, the UK FCA censured NMC Health for market abuse related to debt understatement of as much as US$4 billion, but issued no fine because the insolvent business was not expected to retain funds after satisfying debts. The former NMC Health corporate brand is consequently associated with both the expansion of private healthcare in the UAE and one of the most significant accounting and insolvency crises involving a UAE-founded company listed in London.
- 2023
FCA censure
[1]The UK FCA censured NMC Health for market abuse related to understatement of debt by as much as US$4 billion.
- 2020
Administration and restructuring
[1]NMC disclosed previously unreported financing facilities, entered UK administration and filed for Chapter 15 protection in the United States.
- 2019
Debt-reporting allegations emerge
[1]Muddy Waters challenged NMC's accounts and alleged that the company understated its debt.
- 2018
Aspen Healthcare acquired
[1]NMC Health acquired UK healthcare provider Aspen Healthcare for £10 million.
- 2016
Saudi Arabia entry
[1]NMC acquired a 70 percent stake in As Salama Hospital in Al Khobar and invested in a planned Jeddah care centre.
- 2015
International and specialist-care acquisitions
[1]The company acquired Clínica Eugin and several UAE healthcare groups, including a majority stake in Fakih IVF.
- 2012
London Stock Exchange listing
[1]NMC Health listed its shares on the London Stock Exchange and continued expanding its UAE hospital and management portfolio.
- 2009
Hospital accreditation
[1]NMC hospitals were awarded Joint Commission International accreditation.
- 1996
Expansion beyond Abu Dhabi begins
[1]NMC opened a clinic in Sharjah and began a wider UAE expansion.
- 1981
NMC Trading launched
[1]The group established a medicines marketing and distribution division that later broadened into healthcare supplies, equipment and consumer products.
Products and positioning
A broad private healthcare platform combining hospitals, clinics, specialist and women's-health services, pharmacy operations, long-term care and a healthcare-related distribution business. Before its insolvency, NMC positioned itself as a major UAE private healthcare provider with an increasingly international network and an acquisition-led growth model.
Hospitals and acute care · 1974
NMC hospitals
NMC operated general and specialty hospitals across the UAE, including facilities in Abu Dhabi, Dubai, Al Ain and other emirates. The hospital network provided inpatient and outpatient medicine, diagnostics, surgery and specialist care, and formed the core of the group's private-healthcare identity.
Outpatient healthcare · 1996
NMC clinics and medical centres
The group developed clinics, day-surgery centres and medical centres outside its hospital campuses. These facilities supported accessible outpatient consultations, diagnostics, specialty medicine and follow-up treatment in locations including Sharjah, Dubai, Abu Dhabi and Al Ain.
Women's health and reproductive medicine · 2015
NMC women's health and fertility services
NMC built a specialist platform spanning gynecology, obstetrics, fertility and human reproduction. Acquisitions including Clínica Eugin and a 51 percent stake in Fakih IVF expanded the group's reproductive-health capabilities and supported its stated ambition to cover women's care from fertility through obstetrics and pediatrics.
Long-term care and rehabilitation · 2015
Provita and Americare services
Through Provita and Americare, NMC participated in long-term care, rehabilitation and related specialist services. These operations complemented acute hospitals by addressing continuing care and recovery needs.
Healthcare distribution · 1981
NMC Trading
NMC Trading distributed pharmaceuticals, medical equipment and medical supplies and later expanded into fast-moving consumer goods, cosmetics and educational products. The business held distribution relationships for brands including Nestlé, Pfizer, Siemens, Samsung, Sanofi and Henkel, according to the referenced company account.
Retail pharmacy
Pharmacy retail
Pharmacy operations complemented NMC's clinical network and provided retail access to medicines and related healthcare products. The group was reported to operate more than 15 pharmacies during its pre-insolvency expansion period.
Controversies
2023
Financial Conduct Authority market-abuse censure
The FCA censured NMC Health for market abuse involving debt understatement of as much as US$4 billion. No fine was imposed because the insolvent company was not expected to have funds available after creditor payments.
2020
Undisclosed financing facilities and insolvency
NMC disclosed more than US$2.7 billion of previously unreported financing facilities. The resulting liquidity and governance crisis contributed to share suspension, creditor actions and UK administration.
2020
UK accounting regulator investigates EY over NMC Health audits
The UK accounting regulator opened an investigation into EY concerning its audit of NMC Health. The source does not state when the investigation was opened. The event is recorded as a controversy note in the Brand Wiki, summarizing only the fact of the investigation and the identity of the audit firm involved. No findings, penalties, or conclusions are attributed to EY or NMC Health in the source material used for this note. The note is limited to the information provided and does not add further details about the scope, timing, or outcome of the investigation.
2019
Alleged understatement of debt
Muddy Waters alleged that NMC Health had manipulated its balance sheet and understated debt. The allegations triggered a broader review of the company's accounts and financing arrangements.
Brand decisions
2020
Commence insolvency administration and cross-border protectionStrategyBackground
Previously undisclosed debt facilities and alleged financial irregularities left NMC insolvent and exposed it to creditor and regulatory proceedings in multiple jurisdictions.
Action taken
The company entered UK administration and later filed for Chapter 15 protection in the United States.
Aftermath
Administrators pursued restructuring and asset-value preservation, while the London listing remained suspended and the former corporate brand ceased operating as an independent active group.
2018
Acquire Aspen HealthcareM&ABackground
NMC continued its international acquisition program and sought a larger UK healthcare presence.
Action taken
NMC Health acquired Aspen Healthcare for £10 million.
Aftermath
The acquisition expanded the group's UK healthcare interests before the later financial crisis and administration.
Acquisition consideration. £10 million (August 2018)
2016
Enter the Saudi healthcare marketStrategyBackground
NMC sought growth outside the UAE while extending its hospital and continuing-care capabilities.
Action taken
NMC acquired a 70 percent stake in As Salama Hospital in Al Khobar and invested in a planned care centre in Jeddah.
Aftermath
Saudi Arabia became part of NMC's international operating footprint.
2015
Expand into fertility and specialist healthcareM&ABackground
NMC aimed to broaden beyond general hospitals and build an integrated women's-health platform.
Action taken
The company acquired Clínica Eugin, several UAE healthcare groups and a 51 percent stake in Fakih IVF.
Aftermath
The acquisitions increased NMC's presence in fertility, women's health, long-term care and rehabilitation.
2012
List the company on the London Stock ExchangeStrategyBackground
NMC sought public-market capital and visibility while expanding its UAE healthcare platform.
Action taken
NMC Health listed on the London Stock Exchange in April 2012.
Aftermath
The listing supported an increasingly international acquisition and expansion strategy, but later subjected the company to UK market-disclosure and regulatory scrutiny.
Recent events
- 2020
NMC Health files for Chapter 15 protection[1]
Bankruptcy
NMC Health sought Chapter 15 bankruptcy protection in the United States to help administrators preserve and realize value from US-based assets.
- 2020
B. R. Shetty sells NMC Health for nominal consideration[1]
M&A · Bankruptcy
In December, Shetty sold the company for one US dollar to an Israeli-UAE consortium as the group underwent insolvency and restructuring proceedings.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/nmc-health · Editorial policy · How profiles are compiled